Matches in Wikidata for { <http://www.wikidata.org/entity/Q92710383> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q92710383 description "artículu científicu espublizáu n'abril de 2019" @default.
- Q92710383 description "im April 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92710383 description "scientific article published on 01 April 2019" @default.
- Q92710383 description "wetenschappelijk artikel" @default.
- Q92710383 description "наукова стаття, опублікована 1 квітня 2019" @default.
- Q92710383 name "Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System" @default.
- Q92710383 name "Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System" @default.
- Q92710383 type Item @default.
- Q92710383 label "Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System" @default.
- Q92710383 label "Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System" @default.
- Q92710383 prefLabel "Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System" @default.
- Q92710383 prefLabel "Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System" @default.
- Q92710383 P1433 Q92710383-31E2FD8C-E8AE-4AC4-865F-56D50EA50924 @default.
- Q92710383 P1476 Q92710383-54B107F4-24B0-4F28-AAF3-1F42844778FA @default.
- Q92710383 P2093 Q92710383-170B016E-EA7E-410B-8874-11412D751D56 @default.
- Q92710383 P2093 Q92710383-6579522E-686F-467E-8EAC-45D32C62B62B @default.
- Q92710383 P2093 Q92710383-6FDEB612-BF29-4E3A-BE6A-AA25589F20D6 @default.
- Q92710383 P2093 Q92710383-785E0145-FB0F-4BBE-88E8-B42774F81F05 @default.
- Q92710383 P2093 Q92710383-92049B7A-80FC-47F7-BC31-EED9177247D0 @default.
- Q92710383 P2093 Q92710383-A773672F-32E7-47E1-A698-F7F3C97FD9B6 @default.
- Q92710383 P2093 Q92710383-EC5AD249-14F2-4322-9113-89BFFAAE0F60 @default.
- Q92710383 P304 Q92710383-2B956DBF-8C50-4665-BF4A-408FE3CD5A09 @default.
- Q92710383 P31 Q92710383-239D98B5-B83E-4318-9FA7-3221DFA179B3 @default.
- Q92710383 P356 Q92710383-7B58DBEB-23F6-4218-A34F-5E2F6AB57B82 @default.
- Q92710383 P407 Q92710383-257BB34C-5065-4C67-AE33-07BC8923E507 @default.
- Q92710383 P433 Q92710383-C0EBD8EC-A3B8-4B6F-B5A4-6A045D533E17 @default.
- Q92710383 P478 Q92710383-B9FCCD46-C445-4B9D-86E8-A04DD7148FE5 @default.
- Q92710383 P50 Q92710383-1CA57798-F0D4-4C5D-8139-B0D52887D644 @default.
- Q92710383 P50 Q92710383-67C8522F-A348-4FF8-866C-DC4995212507 @default.
- Q92710383 P577 Q92710383-9302EACB-0999-47FD-A246-9B038FA90187 @default.
- Q92710383 P698 Q92710383-6482156D-CE42-4F17-A806-B7B6023C0C8B @default.
- Q92710383 P356 S11523-019-00632-W @default.
- Q92710383 P698 30927173 @default.
- Q92710383 P1433 Q25378200 @default.
- Q92710383 P1476 "Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System" @default.
- Q92710383 P2093 "Alessandra Mazzarella" @default.
- Q92710383 P2093 "Elisabetta Poluzzi" @default.
- Q92710383 P2093 "Emanuele Forcesi" @default.
- Q92710383 P2093 "Fabrizio De Ponti" @default.
- Q92710383 P2093 "Marco Tuccori" @default.
- Q92710383 P2093 "Nicolò Bendinelli" @default.
- Q92710383 P2093 "Ugo Moretti" @default.
- Q92710383 P304 "205-221" @default.
- Q92710383 P31 Q13442814 @default.
- Q92710383 P356 "10.1007/S11523-019-00632-W" @default.
- Q92710383 P407 Q1860 @default.
- Q92710383 P433 "2" @default.
- Q92710383 P478 "14" @default.
- Q92710383 P50 Q37836555 @default.
- Q92710383 P50 Q56343994 @default.
- Q92710383 P577 "2019-04-01T00:00:00Z" @default.
- Q92710383 P698 "30927173" @default.